Omeros (OMER) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -13.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.84% |
| Dec 31, 2025 | -19.03% |
| Sep 30, 2025 | -39.39% |
| Jun 30, 2025 | -27.93% |
| Mar 31, 2025 | -35.67% |
| Dec 31, 2024 | -24.10% |
| Sep 30, 2024 | -22.59% |
| Jun 30, 2024 | -18.31% |
| Mar 31, 2024 | -6.68% |
| Dec 31, 2023 | -10.89% |
| Sep 30, 2023 | -5.42% |
| Jun 30, 2023 | -10.16% |
| Mar 31, 2023 | -5.29% |
| Dec 31, 2022 | -0.54% |
| Sep 30, 2022 | 3.21% |
| Jun 30, 2022 | -5.13% |
| Mar 31, 2022 | 4.88% |
| Dec 31, 2021 | 25.35% |
| Sep 30, 2021 | 24.81% |
| Jun 30, 2021 | 1.28% |
| Mar 31, 2021 | 3.32% |
| Dec 31, 2020 | 5.50% |
| Sep 30, 2020 | 7.94% |
| Jun 30, 2020 | 6.86% |
| Mar 31, 2020 | 1.99% |
| Dec 31, 2019 | -6.18% |
| Sep 30, 2019 | 11.31% |
| Jun 30, 2019 | 11.29% |
| Mar 31, 2019 | -8.62% |
| Dec 31, 2018 | 6.87% |
| Sep 30, 2018 | 7.22% |
| Jun 30, 2018 | 8.02% |
| Mar 31, 2018 | 5.62% |
| Dec 31, 2017 | -5.47% |
| Sep 30, 2017 | 22.24% |
| Jun 30, 2017 | 24.32% |
| Mar 31, 2017 | 22.37% |
| Dec 31, 2016 | 28.61% |
| Sep 30, 2016 | 4.66% |
| Jun 30, 2016 | 35.03% |
| Mar 31, 2016 | 59.34% |
| Dec 31, 2015 | 4.80% |
| Sep 30, 2015 | 60.38% |
| Jun 30, 2015 | 61.12% |
| Mar 31, 2015 | 30.56% |
| Dec 31, 2014 | 103.51% |
| Sep 30, 2014 | 52.77% |
| Jun 30, 2014 | 43.90% |
| Mar 31, 2014 | 57.46% |
| Dec 31, 2013 | 46.21% |
| Sep 30, 2013 | 56.76% |